High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1

Archives of Virology

Volumn 152, Issue 6, 2007, Pages 1069-1073

  Tan, C S ^a   Cardosa, M J ^a  

^a UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; PEPTIDE FRAGMENT; VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; BLOOD; CHEMISTRY; ENTEROVIRUS; ENTEROVIRUS INFECTION; FETUS BLOOD; GENETICS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; NEWBORN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; SERODIAGNOSIS; VIROLOGY;

ANTIBODIES, VIRAL; BASE SEQUENCE; CAPSID PROTEINS; DNA, VIRAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; EPITOPES; FETAL BLOOD; HUMANS; INFANT, NEWBORN; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS;

HUMAN ENTEROVIRUS 71; MIRIDAE;

EID: 34249016430     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-007-0941-1     Document Type: Article

References (10)

1. Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, McMinn P (2003) Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 9: 461-468
2. Jimenez-Clavero MA, Escribano-Romero E, Douglas AJ, Ley V (2001) The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry. J Virol 75: 1044-1047
3. Kanno T, Inoue T, Wang Y, Sarai A, Yamaguchi S (1995) Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants. J Gen Virol 76 (Pt 12): 3099-3106
4. McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ (2001) Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 75: 7732-7738
5. McMinn PC (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91-107
6. Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K (2005) Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol 43: 6171-6175
7. Pulli T, Roivainen M, Hovi T, Hyypia T (1998) Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. J Gen Virol 79 (Pt 9): 2249-2253
8. van der Werf S, Wychowski C, Bruneau P, Blondel B, Crainic R, Horodniceanu F, Girard M (1983) Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc Natl Acad Sci USA 80: 5080-5084
9. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS (2001) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20: 895-904
10. Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ (2000) Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7: 523-528